Thank you to Simone Fishburn, BioCentury's Editor in Chief, for having our CEO, Jeremy Bender, on The #BioCenturyShow's recent episode to talk about Day One Biopharmaceuticals' approach to drug development and its strategy for long-term sustainability. Listen to the full episode here: https://bit.ly/3RYf560
On The #BioCenturyShow, Day One Biopharmaceuticals CEO Jeremy Bender joined BioCentury's Editor in Chief Simone Fishburn to talk: ➤ Pediatric cancer drug development, with opportunities for adult applications ➤ First v. best in class ➤ Advancements with ADCs ➤ How to turn a start-up into a commercial entity at lightening speed Watch the full interview now on YouTube or listen to "The BioCentury Show" on your favorite podcast platform: https://lnkd.in/gKkZuRqN Learn more: https://lnkd.in/gguT9TcA #drugdevelopment #pediatriccancer #ADCs